COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge

Cancer Cell. 2022 Jun 13;40(6):578-580. doi: 10.1016/j.ccell.2022.04.015. Epub 2022 Apr 21.

Authors

Affiliations

¹ Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
² Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: iritavi@tlvmc.gov.il.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
SARS-CoV-2

Supplementary concepts

SARS-CoV-2 variants